0.0040EUR+11.11%Mkt Cap: 354765 EURP/E: —Last update: 2026-05-22
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic at…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap354.76K EUR
Enterprise Value10.84M EUR
Revenue (TTM)2.00K EUR
Gross Profit555.00K EUR
Net Income (TTM)-3.73M EUR
Revenue/Share0.0000 EUR
Last Price0.0040 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees11
CountryBE
SectorHealthcare
IndustryBiotechnology
ISINBE0003846632
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA11.89
EV/Revenue5420.90
P/S159.64
P/B-0.00
EPS (TTM)-0.13
EPS (Forward)-0.47
52W Range
0.00360% of range0.0840
52W High0.0840 EUR
52W Low0.0036 EUR
Profitability
Gross Margin100.00%
Oper. Margin45050.00%
EBITDA Margin45600.00%
Profit Margin-671.71%
ROE28.92%
ROA-97.46%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.71M EUR
CapEx (TTM)—
FCF Margin-110843.75%
FCF Yield-624.89%
Net Debt10.82M EUR
Net Debt/EBITDA11.87
Balance Sheet
Debt/Equity-0.89
Current Ratio0.17
Quick Ratio0.17
Book Value/Sh-2.4250 EUR
Cash/Share0.0010 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10000
Split DateSep 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.88.69M
Float4.28M
Insiders9.67%
Institutions0.00%
Technical
SMA 500.0045 (-11.3%)
SMA 2000.0107 (-62.6%)
Beta-0.15
S&P 52W Chg28.31%
Avg Vol (30d)668.21K
Avg Vol (10d)351.73K
Technical Indicators
RSI (14)40.9
MACD-0.0002
MACD Signal-0.0003
MACD Hist.+0.0000
BB Upper0.0043 EUR
BB Middle0.0039 EUR
BB Lower0.0035 EUR
BB Width19.39%
ATR (14)0.0003 EUR
Vol Ratio (20d)0.12x